Study Finds New Pathway for Antidepressants

Researchers with the U.S. Department of Energy Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a way in which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

TREK1 activity has been implicated in mood regulation and could be an important target for fluoxetine and other antidepressant drugs.

"Whereas the